Join to access to all OVN content. Join for Free
INTENTION: How to Get What You Want and Achieve Your Goals
goal-setting strategies effective goal achievement daily intention strategy overcoming overwhelm personal and professional success

INTENTION: How to Get What You Want and Achieve Your Goals


Share This Article


Summary

E86 • Jan 11, 2022 • 26 mins

In this episode, Tom Caravela delves into effective goal-setting strategies as the New Year approaches. He emphasizes the significance of setting deadlines and scheduling to ensure goal achievement. Tom discusses the delicate balance between growth and comfort, highlighting how daily actions can prevent overwhelm and propel progress. He underscores the transformative power of setting daily intentions, providing listeners with practical tips to enhance their personal and professional success. Whether you're an MSL or in a different field, these insights aim to help you navigate the year ahead with clarity and purpose.

Tom Caravela discusses the power of INTENTION: How to get what you want and achieve your goals

Learn…

πŸ‘‰ 8 Tips for defining your goals

πŸ‘‰ How to handle overthinking and being overwhelmed

πŸ‘‰ Daily Intention Strategy – 3 step process

πŸ‘‰ The science behind intention and why it works

πŸ‘‰ What a Daily Intention Strategy will do for you

Click for Source
goal-setting strategies, effective goal achievement, daily intention strategy, overcoming overwhelm, personal and professional success

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Explore OVN